[English] 日本語
Yorodumi- PDB-9zrz: Cryo-EM structure of SHIV-elicited CI93-1365 Fab in complex with ... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9zrz | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of SHIV-elicited CI93-1365 Fab in complex with HIV Env trimer Q23-SCT27 | |||||||||||||||||||||
Components |
| |||||||||||||||||||||
Keywords | VIRAL PROTEIN/IMMUNE SYSTEM / immune complex / neutralization / SHIV / HIV V2 apex / VIRAL PROTEIN / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||||||||||||||
| Function / homology | Function and homology informationpositive regulation of plasma membrane raft polarization / symbiont-mediated perturbation of host defense response / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell ...positive regulation of plasma membrane raft polarization / symbiont-mediated perturbation of host defense response / positive regulation of receptor clustering / host cell endosome membrane / clathrin-dependent endocytosis of virus by host cell / viral protein processing / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / membrane Similarity search - Function | |||||||||||||||||||||
| Biological species | ![]() ![]() Human immunodeficiency virus | |||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.9 Å | |||||||||||||||||||||
Authors | Roark, R.S. / Shapiro, L.S. / Kwong, P.D. | |||||||||||||||||||||
| Funding support | United States, 1items
| |||||||||||||||||||||
Citation | Journal: Nature / Year: 2026Title: Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies. Authors: Lorie Marchitto / Kshitij Wagh / Ryan S Roark / Severin Coleon / Hui Li / Ashwin N Skelly / Michael P Hogarty / Rumi Habib / Wenge Ding / Kasirajan Ayyanathan / Weimin Liu / Zizhang Sheng / ...Authors: Lorie Marchitto / Kshitij Wagh / Ryan S Roark / Severin Coleon / Hui Li / Ashwin N Skelly / Michael P Hogarty / Rumi Habib / Wenge Ding / Kasirajan Ayyanathan / Weimin Liu / Zizhang Sheng / Yicheng Guo / Joena Bal / Lena M Smith / Laura L Sutherland / Younghoon Park / Andrew J Connell / Frederic Bibollet-Ruche / Emily Lewis / Samantha J Plante / Macy J Akeley / Jinery Lora / Chengyan Zhao / John W Carey / Christian L Martella / Yingying Li / Mary S Campion / Melinda G Lituchy / Rebecca A Osbaldeston / Colette G Gordon / Amie Albertus / Justin Su / Chiaki Noguchi / Ying K Tam / Christopher Barbosa / Bo Liang / Khaled Amereh / Xuduo Li / Agnes A Walsh / Darrell J Irvine / Raiees Andrabi / Robert J Edwards / Edward F Kreider / Drew Weissman / Lawrence Shapiro / Peter D Kwong / Bette T Korber / Barton F Haynes / Kevin O Saunders / Beatrice H Hahn / George M Shaw / ![]() Abstract: Efficient priming of B cell precursors is a rate-limiting step in the induction of V2 apex broadly neutralizing antibodies (bNAbs). Here, we describe a novel germline-targeted HIV-1 Env (CAP256.OPT4) ...Efficient priming of B cell precursors is a rate-limiting step in the induction of V2 apex broadly neutralizing antibodies (bNAbs). Here, we describe a novel germline-targeted HIV-1 Env (CAP256.OPT4) that increases the efficiency of V2 apex bNAb precursor priming by 30-400 fold compared with wild-type HIV-1 Envs and induces - in >90% of macaques - neutralization breadth that includes N130-containing viruses. Using three different delivery platforms - persistently replicating simian human immunodeficiency viruses (SHIVs), protein nanoparticles, and mRNA - we show bNAb priming as early as 4 weeks post-infection or immunization, and neutralization breadth in plasma by 12 weeks. In 14 SHIV-infected macaques, neutralization breadth reached as high as 90% on a 21-virus panel with potency as great as 1:20,000 (50% inhibitory dilution, ID). Monoclonal bNAbs isolated from these animals were similarly broad and potent, with cryo-EM structures representing three distinct lineages revealing canonical needle-like HCDR3 binding. Env-Ab coevolution and structural analyses identified five key residues and loop features under positive selection and temporally associated with neutralization breadth. Importantly, prime-boost immunogens designed to capture these features induced broad and potent neutralization of globally diverse viruses including those containing N130 glycan. Further, rhesus bNAbs were not restricted to IGHD3-15*01 heavy chain alleles. These results expand the utility of the rhesus model for HIV-1 vaccine design and provide a molecular blueprint for inducing V2 apex bNAbs in rhesus and humans. | |||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9zrz.cif.gz | 442.4 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9zrz.ent.gz | 365 KB | Display | PDB format |
| PDBx/mmJSON format | 9zrz.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/zr/9zrz ftp://data.pdbj.org/pub/pdb/validation_reports/zr/9zrz | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 74656MC ![]() 9zrxC ![]() 9zryC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Protein , 2 types, 6 molecules bdfceg
| #3: Protein | Mass: 56731.629 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Human immunodeficiency virus / Gene: env / Production host: Homo sapiens (human) / References: UniProt: O55774#4: Protein | Mass: 17205.666 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Human immunodeficiency virus / Gene: env / Production host: Homo sapiens (human) / References: UniProt: O55774 |
|---|
-Antibody , 2 types, 2 molecules AB
| #1: Antibody | Mass: 26700.262 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human) |
|---|---|
| #2: Antibody | Mass: 23142.561 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Homo sapiens (human) |
-Sugars , 5 types, 69 molecules 
| #5: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source #6: Polysaccharide | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta- ...beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source #7: Polysaccharide | Source method: isolated from a genetically manipulated source #8: Polysaccharide | alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D- ...alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | Source method: isolated from a genetically manipulated source #9: Sugar | ChemComp-NAG / |
|---|
-Details
| Has ligand of interest | N |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: CI93-1365 Fab in complex with HIV envelope trimer / Type: COMPLEX / Entity ID: #1-#4 / Source: RECOMBINANT | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source (natural) |
| ||||||||||||
| Source (recombinant) | Organism: Homo sapiens (human) | ||||||||||||
| Buffer solution | pH: 7.5 / Details: PBS | ||||||||||||
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||
| Vitrification | Cryogen name: ETHANE / Humidity: 100 % |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: OTHER |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 2000 nm / Nominal defocus min: 800 nm |
| Image recording | Electron dose: 58 e/Å2 / Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.9 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 132734 / Symmetry type: POINT | ||||||||||||||||||||||||
| Atomic model building | Protocol: AB INITIO MODEL | ||||||||||||||||||||||||
| Refinement | Highest resolution: 2.9 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi





Human immunodeficiency virus
United States, 1items
Citation





PDBj





Homo sapiens (human)
FIELD EMISSION GUN